Seer, Inc. - Class A

The momentum for this stock is not very good. Seer, Inc. - Class A is not very popular among insiders. Tradey thinks it is not wise to invest in Seer, Inc. - Class A.

News

Seer (NASDAQ:SEER) Trading Down 1.2%

Zolmax Seer, Inc. (NASDAQ:SEER - Get Free Report)'s stock price dropped 1.2% on Monday . The company traded as low as $1.61 and last traded at $1.62. Approximately 171,489 shares changed hands during...\n more…

Seer to Participate in the Morgan Stanley 22nd Annual Global Healthcare Conference

Globe Newswire REDWOOD CITY, Calif., Aug. 22, 2024 (GLOBE NEWSWIRE) -- Seer, Inc. (Nasdaq: SEER), a leading life sciences company commercializing a disruptive new platform for proteomics, today announced that the...\n more…

Price T Rowe Associates Inc. MD Acquires 25,441 Shares of Seer, Inc. (NASDAQ:SEER)

Ticker Report Price T Rowe Associates Inc. MD lifted its position in shares of Seer, Inc. (NASDAQ:SEER - Free Report) by 74.5% during the first quarter, according to the company in its most recent filing with the...\n more…

Seer, Inc. (NASDAQ:SEER) Shares Purchased by Vanguard Group Inc.

Ticker Report Vanguard Group Inc. lifted its position in Seer, Inc. (NASDAQ:SEER - Free Report) by 1.0% in the 1st quarter, according to the company in its most recent filing with the Securities and Exchange...\n more…

Seer, Inc. Appoints Dr. Nicolas Roelofs to Board of Directors

TipRanks Financial Blog The latest announcement is out from Seer (SEER). Seer, Inc. has appointed Nicolas Henry Roelofs, Ph.D., to its board with his term set to expire at the 2025 annual ...\n more…

Seer (NASDAQ:SEER) Given New $3.00 Price Target at Morgan Stanley

Zolmax Seer (NASDAQ:SEER - Get Free Report) had its price objective decreased by research analysts at Morgan Stanley from $7.00 to $3.00 in a note issued to investors on Tuesday, Benzinga reports. The firm...\n more…